Loading...
OTCM
BICX
Market cap6mUSD
Dec 04, Last price  
0.35USD
1D
0.00%
1Q
20.74%
IPO
-91.82%
Name

BioCorRx Inc

Chart & Performance

D1W1MN
OTCM:BICX chart
P/E
P/S
857.39
EPS
Div Yield, %
Shrs. gr., 5y
24.32%
Rev. gr., 5y
-49.79%
Revenues
8k
-91.40%
000771,762868,161714,9621,170,922924,732701,772657,271376,656240,259122,62148,272213,84189,1607,665
Net income
-5m
L+35.55%
-5,021-13,197-23,086-408,967-885,807-3,838,522-3,127,780-4,665,990-5,903,982-29,705,669-6,511,891-7,708,270-4,014,989-5,803,167-4,369,413-3,766,913-5,106,124
CFO
-1m
L-40.85%
-1,046-7,750-15,510-129,290-927,758103,458167,66947,859-1,987,100-2,540,395-1,825,623-2,937,127-2,151,872-3,537,658-2,041,773-1,853,282-1,096,254

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
IPO date
Aug 31, 2010
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT